Breast reconstruction surgery means meticulous craftsmanship by experienced surgeons
Reconstructing a removed breast is part of the treatment path of many breast cancer patients. The goal of the surgery...
Read moreCookies at Docrates Oy
Cookies are used on our website to provide Docrates Oy’s services, to develop services, to improve the user experience and to target marketing. A cookie is a text file that is stored in your device’s or browser’s cache when you visit the Docrates Oy (“Docrates”) website. This cookie file contains a small amount of information that is read by the website when you visit it. The cookies ensure that the website functions and operates as efficiently as possible. They also provide us with information that allows us to provide you with a good user experience.
Some of the cookies used on Docrates’ website are necessary for the functioning of the website -as these essential cookies enable the core functionalities of the website. You cannot opt out of these cookies except by changing your browser settings – however, the website and all its services may no longer function normally.
Some cookies are instead used to improve your experience on the website. You can accept or decline these cookies in the cookie banner that appears when you visit Docrates’ pages for the first time.
General purposes of employing cookies
Cookies have several different uses. These purposes can be divided into the following general categories:
| Ändamål | Beskrivning |
| Strictly Necessary Cookies | These cookies are essential for our Services to function properly and to ensure that our Services are protected from unusual activity. These cookies are usually only set in response to actions and requests made by you, such as when you use the chat function. |
| Analytiska cookies | These cookies are often used to improve the performance of our website, as they allow us to analyse visitor flows and the number of users. We use these cookies to collect information about which pages you find most interesting and to improve our website. |
| Prestandacookies | These cookies are used to enhance the performance of our Services by for example making sure that the website you visit loads faster. Generally, the information collected is of basic nature and may include information relating to the type of browser that is typically used. This information will, amongst other things, help us to analyze the flow of visitors and users. |
| Advertising Cookies | These cookies are typically used to market our Services, usually through third-party sites, by collecting information about your browsing habits and how you navigate within our Services. This in turn enables us to make our content and advertising as relevant to you as possible. |
Modifications to our cookie notice
We may update this cookie notice from time to time. Please make sure to check our Services or website if we have made any updates to this notice. The most recent version will always be available within the Services. For information on when the cookie notice was last updated, please refer to the date at the top of the cookie notice.
Contact information for Docrates Oy
If you have any questions about Docrate’s use of cookies or would like to contact us for any other reason, please find our contact details below:
tietosuoja@docrates.com
Docrates Cancer Center
Saukonpaadenranta 2
00180 Helsinki
List of cookies used on Docrates Oy’s website
| NAME | PROVIDER | PURPOSE | CATEGORY | VALID |
| CookieConsent | Cookiebot | Keeps information about cookie consent | Essential | 1 year |
Last updated: 26.10.2022
List of cookies used on Docrates Oy's website
Open list
Read more
Chief Clinical Director of Docrates Cancer Center: “Genetic information is an essential part of modern cancer care”
New forms of treatment based on molecular diagnostics enable more and more patients to completely recover from cancer, and make...
Customer message 3. September, 2024
With a transaction signed on 2 September 2024, Mehiläinen has acquired Docrates Ltd, as a result of which Docrates Cancer...
The competition authority issues its decision on the merger of Mehiläinen and Docrates Cancer Center
On 27, August 2024, the Finnish Competition and Consumer Authority (FCCA) approved the merger of Mehiläinen and Docrates Cancer Center....
Why come to Docrates Cancer Center?
- Top cancer experts and effective treatments without delay.
- Individual care. You have your own care team - your doctor and your nurse.
- Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
- Experience in treating international patients from over 60 countries. Multilingual personnel.
+358 10 773 2010
Contact us!
Mon-Thu 8:00-18:00, Fri 8:00-16:00
